Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.

Beaufils, Mathilde; Amodru, Vincent; Tejeda, Manuel; Boher, Jean Marie; Zemmour, Christophe; Chanez, Brice; Chrétien, Anne Sophie; Gorvel, Laurent; Gravis, Gwenaelle; Bruyat, Damien; Mari, Roxane; Madroszyk, Anne; Cuny, Thomas; Gonçalves, Anthony; Lisberg, Aaron E; Olive, Daniel; Tassy, Louis; Castinetti, Frederic; Rochigneux, Philippe

Beaufils, Mathilde; Amodru, Vincent; Tejeda, Manuel; Boher, Jean Marie; Zemmour, Christophe; Chanez, Brice; Chrétien, Anne Sophie; Gorvel, Laurent; Gravis, Gwenaelle; Bruyat, Damien; Mari, Roxane; Madroszyk, Anne; Cuny, Thomas; Gonçalves, Anthony; Lisberg, Aaron E; Olive, Daniel; Tassy, Louis; Castinetti, Frederic; Rochigneux, Philippe.

Affiliation

Beaufils M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Amodru V; Department of Endocrinology, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
Tejeda M; Department of Informatics, Institut Paoli-Calmettes, Marseille, France.
Boher JM; Department of Biostatistics, Institut Paoli-Calmettes, Marseille, France.
Zemmour C; Department of Biostatistics, Institut Paoli-Calmettes, Marseille, France.
Chanez B; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Chrétien AS; Tumor Immunology, CRCM Marseille, Inserm 1068 - CNRS 7258 - Institut Paoli Calmettes - Aix Marseille University, Marseille, France.
Gorvel L; Tumor Immunology, CRCM Marseille, Inserm 1068 - CNRS 7258 - Institut Paoli Calmettes - Aix Marseille University, Marseille, France.
Gravis G; Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Bruyat D; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Mari R; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Madroszyk A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Cuny T; Department of Endocrinology, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Lisberg AE; Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.
Olive D; Tumor Immunology, CRCM Marseille, Inserm 1068 - CNRS 7258 - Institut Paoli Calmettes - Aix Marseille University, Marseille, France.
Tassy L; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Castinetti F; Department of Endocrinology, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
Rochigneux P; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France rochigneuxp@ipc.unicancer.fr.

J Immunother Cancer ; 11(8)2023 08.

Article de En | MEDLINE | ID: mdl-37536938

Sujet(s)
Mots clés

Immune Checkpoint Inhibitors; Immunotherapy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Inhibiteurs de points de contrôle immunitaires / Tumeurs Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Humans Langue: En Journal: J Immunother Cancer Année: 2023 Type de document: Article Pays d'affiliation: France Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google